Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Letters to the Editor

Longitude Position in a Time Zone and Cancer Risk—Response

Neil E. Caporaso, Fangyi Gu, Elizabeth B. Klerman, Susan S. Devesa, Rena R. Jones, Fanni Zhang, Elizabeth K. Cahoon and Barry I. Graubard
Neil E. Caporaso
1Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: caporaso@nih.gov
Fangyi Gu
2Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth B. Klerman
3Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Division of Sleep Medicine and Harvard Medical School, Boston, Massachusetts.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan S. Devesa
1Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rena R. Jones
1Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fanni Zhang
4Information Management Services, Inc., Rockville, Maryland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth K. Cahoon
1Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barry I. Graubard
1Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-17-1199 Published September 2018
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

We are happy to reply to the points raised by William B. Grant (1), who states that UVB exposure (rather than circadian disruption) may account for our findings of increased cancer rates associated with western position in U.S. time zones based on an ecologic analysis we conducted using SEER data (2).

First, some corrections to Dr. Grant's text (1). Although we included latitude in our models, our findings implicate westerly position in the time zone or longitude, not latitude, as a risk factor, consistent with circadian disruption. Latitude alters day length, angle of the sun, temperature, and other factors and therefore all our analyses included it as a potentially confounding variable. The shift in longitude for each time zone is 15 degrees (not 20). The adjusted rate ratio elevations for all cancers we reported are for 20 minutes (=5 degrees longitude) and were close to 4% in females and 3% in men.

Second, we disagree with Dr. Grant's assertion that the findings are random with respect to individual cancers. For example, risks associated with female breast (3), prostate (4), uterine corpus (5), and chronic lymphocytic leukemia (CLL) (6) are consistent with the previous literature that reported elevated risk in shift workers.

Third, given our broad findings involving multiple cancers, we chose to include only a limited number of important covariates in our analyses. Future studies focusing on individual cancers should emphasize specific confounders as appropriate, although information on many potential confounders is not routinely available at the county level. Conducting analytic epidemiology studies in populations where individual data can be incorporated will be an important next step.

Finally, we conducted the analyses suggested by Dr. Grant. We excluded California and Washington counties and limited the analysis to non-Hispanic whites. The findings are similar to Table 1 from our original work (1) with some attenuation due to the reduction in sample size. Next, using the full data, we controlled for UVB using data based on county-level summertime ambient UVB estimates. These results again were similar to our original findings (1). While some of the results are attenuated consistent with a degree of collinearity between sunlight (which drives the daily reset of the biological clock in humans) and UVB exposure, we note that Bonferroni thresholds for statistical significance are achieved for all cancers (both genders), prostate, uterine corpus, and CLL in men among others (Table 1). While there are ecologic and observational epidemiology data associating UV radiation exposure with both increased (melanoma) and decreased (non–Hodgkin lymphoma, colon, others) cancer incidence (7), additional study including mediation analyses are needed to investigate alternative potential mechanisms such as vitamin D, activity/inactivity, sleep alterations, obesity and insulin resistance.

View this table:
  • View inline
  • View popup
Table 1.

Association between position in a time zonea and age-adjusted county level cancer incidence among whites adjusting for summertime UVBb in 11 states within the continental United States, SEER program 2000–2012c

In conclusion, based on the previous findings (1) and these additional analyses, circadian disruption remains the most plausible explanation for the elevated relative risk of diverse cancers in the western regions of time zones in the United States. Given the broad impact of circadian biology on human health (8) and accelerating genetic (9, 10) understanding, further population-based studies to investigate its impact are a priority.

See the original Letter to the Editor, p. 1110

Disclosure of Potential Conflicts of Interest

E.B. Klerman is a consultant/advisory board member for Pfizer Pharmaceuticals and has provided expert testimony for Sleep Research Society. No potential conflicts of interest were disclosed by the other authors.

  • Received January 12, 2018.
  • Revision received February 20, 2018.
  • Accepted March 5, 2018.
  • Published first September 1, 2018.
  • ©2018 American Association for Cancer Research.

References

  1. 1.↵
    1. Grant WB
    . Longitude position in a time zone and cancer risk—Letter. Cancer Epidemiol Bomarkers Prev 2018;27:1110.
    OpenUrl
  2. 2.↵
    1. Gu F,
    2. Xu S,
    3. Devesa SS,
    4. Zhang F,
    5. Klerman EB,
    6. Graubard BI,
    7. et al.
    Longitude position in a time zone and cancer risk in the United States. Cancer Epidemiol Biomarkers Prev 2017;26;1306–11.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Yang WS,
    2. Deng Q,
    3. Fan WY,
    4. Wang WY,
    5. Wang X
    . Light exposure at night, sleep duration, melatonin and breast cancer: a dose-response analysis of observational studies. Eur J Cancer Prev 2014;23:269–76.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Wendeu-Foyet MG,
    2. Menegaux F
    . Circadian disruption and prostate cancer risk: an updated review of epidemiological evidence. Cancer Epidemiol Biomarkers Prev 2017;26:985–91.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Viswanathan AN,
    2. Hankinson SE,
    3. Schernhammer ES
    . Night shift work and the risk of endometrial cancer. Cancer Res 2007;67:10618–22.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Costas L,
    2. Benavente Y,
    3. Olmedo-Requena R,
    4. Casabonne D,
    5. Robles C,
    6. Gonzalez-Barca EM,
    7. et al.
    Night shift work and chronic lymphocytic leukemia in the MCC-Spain case-control study. Int J Cancer 2016;139:1994–2000.
    OpenUrl
  7. 7.↵
    1. Lin S-W,
    2. Wheeler DC,
    3. Park Y,
    4. Cahoon EK,
    5. Hollenbeck AR,
    6. Freedman DM,
    7. et al.
    Prospective study of ultraviolet radiation exposure and risk of cancer in the US. Int J Cancer 2012;131:E1015–23.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Roenneberg T,
    2. Merrow M
    . The circadian clock and human health. Curr Biol 2016;26:R432–43.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Krishnaiah SY,
    2. Wu G,
    3. Altman BJ,
    4. Growe J,
    5. Rhoades SD,
    6. Coldren F,
    7. et al.
    Clock regulation of metabolites reveals coupling between transcription and metabolism. Cell Metab 2017;25:961–74.
    OpenUrl
  10. 10.↵
    1. Giebultowicz JM
    . Circadian regulation of metabolism and healthspan in Drosophila. Free Radic Biol Med 2017 Dec 19. [Epub ahead of print].
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 27 (9)
September 2018
Volume 27, Issue 9
  • Table of Contents
  • Table of Contents (PDF)
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Longitude Position in a Time Zone and Cancer Risk—Response
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Longitude Position in a Time Zone and Cancer Risk—Response
Neil E. Caporaso, Fangyi Gu, Elizabeth B. Klerman, Susan S. Devesa, Rena R. Jones, Fanni Zhang, Elizabeth K. Cahoon and Barry I. Graubard
Cancer Epidemiol Biomarkers Prev September 1 2018 (27) (9) 1111-1112; DOI: 10.1158/1055-9965.EPI-17-1199

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Longitude Position in a Time Zone and Cancer Risk—Response
Neil E. Caporaso, Fangyi Gu, Elizabeth B. Klerman, Susan S. Devesa, Rena R. Jones, Fanni Zhang, Elizabeth K. Cahoon and Barry I. Graubard
Cancer Epidemiol Biomarkers Prev September 1 2018 (27) (9) 1111-1112; DOI: 10.1158/1055-9965.EPI-17-1199
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Disclosure of Potential Conflicts of Interest
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Copy Number Variation and Ovarian Cancer Risk—Letter
  • Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk—Response
  • Shift Work, Chronotype, and Cancer Risk—Response
Show more Letters to the Editor
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement